Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2019, Article ID 8749291, 7 pages
https://doi.org/10.1155/2019/8749291
Review Article

Effect of Social Factors and the Natural Environment on the Etiology and Pathogenesis of Diabetes Mellitus

1Guang’anmen Hospital, China Academy of Traditional Chinese Medicine, Beijing, China
2Penglai Traditional Chinese Hospital, Shandong, China
3The Third Affiliated Hospital of Beijing University of Chinese Medicine, Beijing, China

Correspondence should be addressed to Junping Wei; moc.621@gnipnujiew

Received 18 March 2019; Accepted 28 April 2019; Published 25 June 2019

Guest Editor: Gaia Mannino

Copyright © 2019 Guangtong Dong et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Type 2 diabetes mellitus (T2DM) is currently a public health problem worldwide and a threat to human health and social development. The incidence rate of the disease is steadily increasing. Various genetic and environmental factors have been established as influencing the pathogenesis of this disease. However, the influence of social factors and the natural environment on DM incidence should also be considered. Low-grade inflammation could represent a central point of connection integrating all these potential triggers, being partly responsible for the development of insulin resistance. This paper aims to elaborate on the impact of the natural environment and social factors on DM development, with a special focus on six aspects of the pathogenesis of DM: pollution, radiation, psychology, drink, sleep, and exercise. We identified a two-way relationship between T2DM and social and natural environments. Changes in these environments may lead to low-grade inflammation, which in turn induces or aggravates T2DM and vice versa. Poor lifestyle may lead to increased insulin resistance and promote DM development. Improvements in blood glucose control can be achieved through nonenvironmental and behavioral interventions.

1. Introduction

Diabetes mellitus (DM) is currently the third most dangerous chronic noncommunicable disease in terms of its effect on human health [1]. Worldwide, the prevalence of the disease is continuously increasing, owing in part to rapid social economy developments, improved living standards, acceleration of urbanization, industrialization, and increase in the proportion of aging individuals. According to the World Health Organization, about 422 million people are currently living with diabetes; this number is expected to increase to 600 million by 2040 [2]. The prevalence rate of DM among adults in China is 11.6% [3]. The dramatic increase in the number of people with DM is among the greatest challenges facing the healthcare sector today. The etiology and pathogenesis of DM are extremely complicated. At present, genetic factors, environmental factors (obesity), and interaction of these two factors have been established as increasing the risk of type 2 diabetes mellitus (T2DM) [4]. However, various social factors and the natural environment may also affect the synthesis and secretion of insulin. Some scholars have discovered that, in a similar setting, low-grade inflammation could represent a central point of connection integrating all these potential triggers, being partly responsible for the development of insulin resistance in recent studies, and may represent a sensor of the consequence of metabolic imbalance [5, 6]. T2DM is associated with an increased inflammatory score. The term ‘metaflammation’ was coined to indicate metabolically triggered inflammation [7]. These six factors are mainly related to T2DM. This paper mainly aims to demonstrate the impact of external and internal factors on the development of T2DM from the perspective of the influence of the natural environment and social factors on individual behavior.

2. Air Pollution

Air pollution is becoming an increasingly serious problem worldwide. Air pollutants can be classified as gaseous pollutants (sulfur compounds, nitrogen compounds, carbon oxides, etc.) and atmospheric particulate matter (PM10 and PM2.5). Several studies have found that environmental factors play an important role in the pathogenesis of T2DM; specifically, air pollution has been shown to be an important catalyst [810]. Andersen et al. [11], in their 9.7-month follow-up study of 51,818 volunteers, demonstrated that people with healthy lifestyles and who regularly exercised had a lower incidence of T2DM than those without these habits in a population of individuals with long-term exposure to traffic-related pollutants. Traffic-related pollutants are among the potential risk factors for T2DM development. Dijkema et al. [12] conducted a cross-sectional study in which 8,018 elderly people were screened for DM. They concluded that the odds of developing type 2 DM increased to 1.39 when NO2 level in the atmosphere increased to 10 mg·m−3. A Chinese study [13] with a large sample showed that the type 2 DM risk index was 1.11 (95% confidence interval [CI]: 1.02–1.21) when the PM2.5 level increased to an average concentration of 10 μg·m−3. Evidence-based medicine supports the idea that air pollution is a risk factor for T2DM, while epidemiological evidence indicates that greater increases in the level of air pollution can cause or increase the prevalence of T2DM. The pathogenesis associated with this increase in the prevalence of T2DM may be attributed to stress-mediated insulin resistance and/or decreased insulin sensitivity, which results in T2DM development through inflammatory response, oxidative stress, and endoplasmic reticulum. The presence of air pollutants in the lungs can stimulate alveolar epithelial cells and macrophages to produce inflammatory factors, such as interleukin and macrophage inflammatory protein 2, and lead to the disorderly interaction of other mediators of systemic inflammatory response [14]. During the process, islet inflammation leads to the destruction or apoptosis of islet cells and insulin sensitivity is reduced, which affects the utilization of glucose by peripheral tissues, thereby increasing the risk of DM. At the same time, when the lungs are stimulated by external pollutants (such as PM2.5), they release reactive oxygen species (ROS) rapidly; the overaccumulation of ROS to levels that exceed those that can be normally removed by the body disrupts the balance between the oxidation and antioxidant systems, resulting in oxidative damage to the tissues and organs [15]. Islet β-cells, which are sensitive to ROS, have low levels of antioxidant enzymes and poor antioxidant capacity. As a result, ROS can directly damage β-cells and lead to DM. Studies have shown that PM10 can increase the proportion of immune cells, malondialdehyde, and neutrophil chemotactic factors in the bronchoalveolar lavage fluid in rats, proving that it can enhance inflammation and the role of oxidative stress in rodents [16]. Islet β-cells are rich in endoplasmic reticulum, and air pollution can mediate endoplasmic reticulum stress. If the stress persists for long periods, the cells initiate an unfolded protein response, activate the apoptotic pathway, induce islet β-cell apoptosis, and affect insulin secretion, leading to T2DM.

3. Radiation Environment

Mobile phones, computers, electronic watches, and other communication equipment have become indispensable in daily life. Radiotherapy is an important treatment modality for cancer. The development of the military industry and demand for alternative energy sources have also led to the establishment of a large number of nuclear power plants. However, long-term exposure to cell phone towers, smart meters, and other radiation-emitting devices can adversely affect human health. Most people know little about the possible relationship between radiation exposure and diabetes [17]. For example, among 8 articles including a systematic review and meta-analysis of 1863 T2DM patients reported by Pettit et al. which identified and analyzed the current evidence on glycemic control (HbA1c) during and after cancer treatment, the effect of radiation on glycemic control is not mentioned [18]. However, it has been considered by the International Commission for Radiation Protection as one factor involved in multifactorial diseases [19].

Existing studies have shown that cancer patients receiving radiotherapy have an increased risk of developing insulin resistance and T2DM [20]. Patients undergoing radiotherapy in whom a dose to the pancreatic tail is 10 Gy or higher have a 11.5 times higher risk of developing DM than those without radiation therapy, suggesting that ionizing radiation exposure may lead to T2DM [20]. In China, a survey has shown that the incidence rates of obesity and metabolic syndrome among those working in nuclear power plants are significantly higher than the national average, indicating that such workers, even after retirement, may have a higher risk of DM than the general population in the corresponding age group [21]. Radiation is a major inducer of inflammatory responses [22]. While radical therapy is over within a short time of radiation exposure, the ensuing inflammatory response perpetuates the response by generating recurring waves of ROS, cytokines, chemokines, and growth factors with associated inflammatory infiltrates [23]. Systemic low-grade inflammatory response and a large number of inflammatory mediators are known pathological features of diabetes [7]. Overexpression of inflammatory factors such as serum C-reactive protein, interleukin (IL)-6, and tumor necrosis factor-α can inhibit insulin secretion and islet function and leads to insulin secretion disorder and insulin resistance, resulting in insufficient insulin secretion and inability to lower blood glucose levels, leading to T2DM and metabolic syndrome [24]. Therefore, we consider that inflammatory responses may be the putative mechanism linking radiation and T2DM.

While radiation exposure increases the risk of T2DM development, T2DM, in turn, increases the degree of radiation damage among cancer patients undergoing radiation therapy. Due to the presence of autonomic neuropathy in diabetic patients, the ability of the parasympathetic nerves to regulate bronchial activity is reduced, and the permeability of patients’ blood vessel walls and sensitivity to ionizing radiation are enhanced, which is not conducive to the absorption and dissipation of inflammatory reactions. Ma et al. [25] showed that DM can aggravate, to an extent, the symptoms of radiation pneumonitis in lung cancer patients. Few studies have focused on the incidence of radiation-induced DM. However, through our review of the aforementioned studies, it can be concluded that radiation can cause diabetes. Diabetes onset may further aggravate the damage caused by radiation, forming a vicious circle. Radiation damage can stimulate the pathogenesis of diabetes; the mutual influence of the two requires further exploration.

4. Psychological Factors

The influence of psychological factors such as depression and anxiety on DM is increasingly being investigated, owing to gradual changes in the social medical model and increasing pressure of life. The “biological-psychological-social medical model" has led to the realization that social and psychological factors play a vital role in the process of DM development and the associated outcomes. According to a report published by the World Health Organization Diabetes Expert Committee, work-related and other psychological burdens may aggravate psychological and social pressures. Furthermore, this situation may induce and produce glucose tolerance-related abnormalities through hormonal action on insulin secretion and glucose metabolism [26]. Engum et al. showed that an increase in the incidence of type 2 DM in people with depressive symptoms regardless of sex in a follow-up survey of 37,291 people conducted over 10 years. Another conclusion is that depression is a significant risk factor for DM development [27]. A meta-analysis of 20 articles, including 45,514 people, showed that the risk of DM in people with stress was 1.80 times higher than that in the normal population [28], showing that blood glucose control alone is not sufficient among people with DM. One of the focus areas of current medical research is understanding the various forms of communication among individuals with diabetes and their family members, partners, friends, and health providers, including the reception of love, care, supervision, motivation, and education [29], and conducting in-depth analyses of the possible associated effects and intervention effects on T2DM; the results may have extensive social benefits as well as research and application prospects. The currently known psychological stress-related mechanisms in terms of T2DM development mainly pertain to the autonomic nervous pathways, neuroendocrine mechanisms, and direct effects on the pancreas. Long-term psychological depression promotes the hypothalamic-pituitary-adrenal axis activity to increase cortisol secretion. The process not only reduces glucose utilization and promotes gluconeogenesis, but also raises blood glucose levels by antagonizing insulin production and inhibiting blood glucose utilization [26]. Tomita et al. [30] showed that depression is a chronic inflammatory response through animal experiments, and changes in inflammatory factor levels can affect the normal metabolism of brain tissue cells. Long-term depression and loss may also lead to pessimism, which could, in turn, lead to lower adherence rates to doctors’ instructions, and the destruction of the original nursing pattern is likely to have a negative impact on blood glucose control. Similarly, some patients who require insulin monitoring and metering adjustments may experience insulin performance task interruptions or a lack of implementation due to emotional factors. Recent studies have pointed out [31] that the occurrence of depressive symptoms is also closely related to the increase of serum inflammatory factors. It can be speculated that DM has a common mechanism of action with depression. By inhibiting the level of serum inflammatory factors, it can not only effectively improve pathological changes caused by T2DM, but also effectively improve depressive symptoms. Some scholars have suggested that there may be a third factor in the mechanism of the interaction between T2DM and psychological stress. Further research should focus on whether the third factor can produce the same results as psychological depression [32].

5. Alcohol Intake

Alcohol intake has become a way of life, with people consuming alcohol to alleviate social pressure. Previous studies have shown a positive correlation between alcohol intake and T2DM development [33], with high intake levels having the potential to damage the liver. The liver is a crucial organ that regulates glucose homeostasis through glycogen synthesis and catabolism. Liver injury can lead to glucose metabolism disorders, resulting in impaired glucose tolerance and DM development. Pathological and ultrastructural abnormalities in chronic alcoholic steatohepatitis are associated with sustained hepatic insulin resistance and proinflammatory cytokine activation [34]. Ethanol intake reduces the sensitivity of islet cells through interference with muscarinic signaling and insulin signaling, resulting in a decrease in the rate of basal insulin secretion. It can be concluded that high alcohol intake levels are closely related to T2DM occurrence. However, another study showed that ethanol intake promotes the expression of insulin signaling and selectively upregulates the insulin transduction pathway by upregulating the expression of intracellular phosphorylated protein kinase B, phosphatidylinositol kinase, and transcription factor pFOX01 and by downregulating the phosphorylation of insulin receptor protein 1 and insulin receptor substrate protein 2 [35]. Moderate drinking can reduce the risk of T2DM. The mechanism is as follows: while moderate drinking can increase the level of high-density lipoprotein, it can lead to significantly reduced levels of serum C-reactive protein, neutrophils, and neutrophil CD64, which may have an anti-inflammatory effect (it is widely accepted that DM is a chronic low-grade inflammatory disease). In addition, moderate drinking can increase the sensitivity of insulin, and ethanol intake can selectively upregulate the insulin signaling pathway in the case of normal blood glucose levels. Therefore, there is a certain dose-effect relationship between alcohol intake and DM development. A cohort study in Korea showed that mild (intake < 5 g/day) and moderate (5 ≤ intake < 30 g/day) alcohol intake reduced the risk of T2DM in men, while high (intake ≥ 30 g/day) alcohol consumption led to increases in the risk of T2DM among men. Therefore, it can be concluded that there is a “J”-type relationship between alcohol consumption and T2DM risk among men [36]. A follow-up survey conducted by Cullmann et al. [37] also showed that heavy drinking increased the risk of pre-diabetes, while the risk of pre-diabetes was lower in those with low or moderate alcohol consumption levels. In women, the risk of DM and its complications is not alleviated by moderate alcohol consumption [38, 39].

6. Lack of Exercise

Rapid economic and technological developments have greatly changed the way people commute, resulting in a significant decline in the levels of daily physical activity. Simultaneously, people also do not have the time for regular exercise owing to the accelerated pace of life or are not interested due to various social pressures. It has been concluded that a lack of exercise is among the risk factors for T2DM, and exercise-based intervention is indispensable for diabetic patients. A meta-analysis performed in the United Kingdom of 1,261,991 people enrolled in 28 cohort studies showed that the risk of T2DM associated with moderate-intensity exercise was reduced by 26% with participation in exercise for 150 min per week, by 36% with participation in exercise for 300 min per week, and by 53% with participation in exercise for 800 min per week compared with that in individuals who did not exercise [40]. The American Diabetes Association and the American Movement recommend that diabetic patients participate in at least 150 min of moderate-to-high-intensity exercise per week [41]. Exercise can accelerate the metabolism of glucose and energy, lead to the consumption of a large amount of glycogen, increase the proportion of capillary and muscle fibers, and promote the intake of glucose in the blood. On the completion of an exercise session, blood glucose is stored in the form of glycogen, leading to further blood glucose reduction. Consumption of glycogen reduces the secretion of insulin, promotes the corresponding receptor binding of insulin in the blood circulation to improve insulin resistance, and enhances glucose metabolism. Exercise can also alleviate tension, improve social adaptability, and alter bad lifestyle-related behavior, which can be crucial for the recovery of people with diabetes. The intensity, duration, and volume of exercise should be gradually increased according to a patient's personal situation, and the load should not exceed the patient's ability to withstand it. For patients with DM, daily training should be adhered to. Exercise can be performed across two or three sessions daily (planned such that they do not coincide with the one or two hours following meal intake) and should combine aerobic and anti-resistance movements. Tai Chi, Baduanjin, Five Animal Qigong, and other traditional Chinese exercises have the characteristics of low-intensity and long-term aerobic exercise. These exercise forms are safe and associated with improved health. By coordinating and adjusting limb movements, one can harmonize body parts to echo his/her physiological status, therefore relaxing muscle tissue and bringing further correction of uncoordinated body posture and spirits. Ultimately, one can react to a status in which mind and body are relaxed and coordinated [42, 43]. In recent years, research studies have reported that Qigong training has certain curative effects in cases of chronic diseases such as T2DM [31]. For instance, the sixth section of Baduanjin, a traditional Chinese Qigong, involves the movement “reaching bilateral hands down to feet to nourish kidneys.” By performing waist flexion and extension, as well as massaging the posterior waist and lower limbs, one’s governor meridian and bladder meridian will be exercised and exerted. This facilitates the flow of Qi-blood circulation and can cause sympathetic nerve excitation and stimulation of the hypothalamic-pituitary-adrenal pathway, promote increases in insulin secretion by β-cells, and lower blood sugar levels; this exercise form also has the effect of regulating water, electrolyte, and acid-base balance [44]. Tai Chi is a traditional Chinese martial art. A large number of studies have confirmed that participation in Tai Chi improves the levels of blood glucose, glycosylated hemoglobin, cholesterol, and other indicators of T2DM and enhances the mechanism of oxidative damage, regulates the balance of the sympathetic and parasympathetic nervous systems, improves immune function, and reduces psychological pressure [45, 46].

7. Sleep-Related Factors

In recent years, people's sleep time has shown a downward trend. The average daily sleep time of Chinese residents is 7.20 h, and the proportion of people with sleep insufficiency is 23.60% [47]. Similarly, the proportion of young Americans who sleep for less than 7 hours/day has risen from 15.6% to 37.1% in the last 40 years [48]. The relationship between sleep and T2DM is a topic of international concern, as a lack of sleep can easily lead to a gradual acceleration in the body’s insulin resistance. Katano et al. showed that sleep disorders showed a clear association with DM [49]. A cross-sectional study found that people with sleep deprivation had fasting blood glucose levels that were increased by 23%, fasting insulin levels that were 48% higher, and an insulin resistance index (homeostatic model assessment of insulin resistance) that was 82% higher compared to those with sufficient sleep [50]. Lack of sleep is also associated with various metabolic disorders, as it enhances sympathetic activity, boosts catecholamine levels, and inhibits pancreatic function, thereby reducing insulin secretion. Current studies have shown that increased levels of inflammatory factors and mediators in patients with sleep disorders, including tumor necrosis factor-α, IL-6, IL-8, high-sensitivity C-reactive protein, transcription factors, and adhesion factors, may affect human health through low-grade inflammation pathways [51, 52]. Increased levels of inflammatory factors are involved in the promotion of insulin resistance by sleep disorders [53]. Difficulties in sleeping reduce the brain's glucose ingestion and insulin sensitivity, impair glucose tolerance, and induce insulin resistance to some extent. The irritability caused by long-term difficulty in falling asleep affects hypothalamic activity, especially in the hypothalamic-pituitary-adrenal axis that is associated with stress [54]. Glucocorticoids are not only responsible for the destructive action of transmembrane glucose transporter 4 (due to which glucose cannot be transported to the cell surface and utilized by the body) but also directly inhibit insulin secretion by islet β-cells. Therefore, elevated cortisol levels caused by sleep problems can also trigger T2DM. Other studies have shown that sleep disorders can lead to metabolic disorders; resistin, leptin, adiponectin, and other cytokines have been shown to mediate insulin resistance, also affecting blood glucose levels [55].

8. Summary

In summary, there is a two-way relationship between T2DM and the social and natural environments; changes in these environments may induce or aggravate T2DM and vice versa. Poor lifestyle can lead to increased insulin resistance and promote T2DM development in some risk groups or environments. However, improvements in blood glucose control can be achieved through interventions that do not rely on environmental and social aspects. Although some epidemiological and mechanistic studies have shown that the natural environment, social factors, and personal behavior are related to T2DM, existing data are insufficient, and results of studies are currently inconsistent.

Some limitations of this study must be considered when interpreting the results. First, the current epidemiological investigation is mainly based on T2DM, and there are many patients with type 1 diabetes mellitus (T1DM) and pre-diabetes. Therefore, it is necessary to broaden the scope of the study to T1DM and gestational diabetes mellitus and pre-diabetes. Most recent studies are cross-sectional in design. Thus, the causal implications of environment and behavior factors for T2DM should be carefully considered. Prospective studies are needed in the future to determine the causal relationship between these risk factors and diabetes. A third limitation is that the results of one measurement do not necessarily reflect the long-term exposure of the human body, so multiple follow-up and determination are required. Fourth, some studies are unable to distinguish individuals with T1DM from those with T2DM, nor can they prove that the investigators evaluated all participants during the relevant survey. Given that the proportion of T1DM patients among all diabetic patients in Korea is less than 1%, we suspect that their inclusion would have had little effect in some studies [56]. Finally, age, gender, and lifestyle habits mentioned in the experimental and epidemiological studies vary widely and may affect the promotion and comparison of the above risk factors with recent study results. For instance, hormonal effects and low statistical power may have contributed to the differences in findings according to sex; thus, the role of endogenous sex hormones in the development of T2DM may have influenced the gender differences noted in this study [57]. Additionally, the insufficient number of females likely resulted in the negative relationship between high-risk female drinkers and the prevalence of T2DM.

Therefore, it is important to perform a more in-depth exploration of the relationship between the aforementioned factors and T2DM. Moreover, there is an urgent need to conduct systematic and deeper research focusing on the pathological mechanism that connects the environment and individual behavior to T2DM. Future clinically relevant and epidemiological studies aimed at achieving comprehensive, optimized interventions can provide a reliable basis for diagnosis and treatment among clinicians.

Conflicts of Interest

The authors declare that there are no conflicts of interest regarding the publication of this paper.

Authors’ Contributions

Junping Wei proposed the paper topic, contributed to this work, and is the corresponding author; Guangtong Dong wrote the paper and is first author; Lianlian Qu searched and reviewed the literature; Xuefeng Gong and Weitian Yan revised the paper. Bing Pang was responsible for subsequent revision of the manuscript.

Acknowledgments

This article was funded by the Chinese National Health and Family Planning Commission Health Bureau Central Health Research Project (W2017BJ43) and the Beijing Chinese Medicine “Fire and Fire Heritage 3+3 Project” (2014-SZ-C-49). The authors thank Editage for linguistic assistance during the preparation of the paper.

References

  1. X. Qi, P. Zhang, Y. Zhanf et al., “Current status of prevention and control strategies for chronic diseases in China,” China Journal of Chronic Disease Prevention and Control, vol. 20, pp. 214–217, 2012. View at Google Scholar
  2. World Health Organization, “Global report on diabetes. Working Papers,” 2016, http://qd.sxsrsc.com:80/rwt02/, http://p75ypluynbyt64lppe/diabetes/global-report/en/.
  3. Y. Xu, L. Wang, J. He et al., “Prevalence and control of diabetes in Chinese adults,” Journal of the American Medical Association, vol. 310, no. 9, pp. 948–958, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Khodaeian, S. Enayati, O. Tabatabaei-Malazy, and M. M. Amoli, “Association between genetic variants and diabetes mellitus in iranian populations: a systematic review of observational studies,” Journal of Diabetes Research, vol. 2015, Article ID 585917, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. F. Prattichizzo, V. De Nigris, E. Mancuso et al., “Short-term sustained hyperglycaemia fosters an archetypal senescence-associated secretory phenotype in endothelial cells and macrophages,” Redox Biology, vol. 15, pp. 170–181, 2018. View at Publisher · View at Google Scholar · View at Scopus
  6. F. Prattichizzo, V. De Nigris, R. Spiga et al., “Inflammageing and metaflammation: The yin and yang of type 2 diabetes,” Ageing Research Reviews, vol. 41, pp. 1–17, 2018. View at Publisher · View at Google Scholar · View at Scopus
  7. G. S. Hotamisligil, “Inflammation, metaflammation and immunometabolic disorders,” Nature, vol. 542, no. 7640, pp. 177–185, 2017. View at Publisher · View at Google Scholar · View at Scopus
  8. A. F. Fleisch, D. R. Gold, S. L. Rifas-Shiman et al., “Air pollution exposure and abnormal glucose tolerance during pregnancy: the project viva cohort,” Environmental Health Perspectives, vol. 122, no. 4, pp. 378–383, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Tamayo, W. Rathmann, U. Krämer, D. Sugiri, M. Grabert, and R. W. Holl, “Is particle pollution in outdoor air associated with metabolic control in type 2 diabetes?” PLoS ONE, vol. 9, no. 3, Article ID e91639, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. P. F. Coogan, L. F. White, M. Jerrett et al., “Air pollution and incidence of hypertension and diabetes mellitus in black women living in Los Angeles,” Circulation, vol. 125, no. 6, pp. 767–772, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. Z. J. Andersen, O. Raaschou-Nielsen, M. Ketzel et al., “Diabetes incidence and long-term exposure to air pollution: a cohort study,” Diabetes Care, vol. 35, no. 1, pp. 92–98, 2012. View at Google Scholar
  12. M. B. Dijkema, S. F. Mallant, U. Gehring et al., “Long-term exposure to traffic-related air pollution and Type 2 diabetes prevalence in a cross-sectional screening-study in the Netherlands,” Environmental Health, vol. 10, no. 1, pp. 76–86, 2011. View at Publisher · View at Google Scholar
  13. Z. Sun, B. Mukherjee, R. D. Brook et al., “Air-Pollution and Cardiometabolic Diseases (AIRCMD): A prospective study investigating the impact of air pollution exposure and propensity for type II diabetes,” Science of the Total Environment, vol. 448, pp. 72–78, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. D. P. Jones, “Radical-free biology of oxidative stress,” American Journal of Physiology-Cell Physiology, vol. 295, no. 4, pp. C849–C868, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. Z. Zheng, X. Xu, X. Zhang et al., “Exposure to ambient particulate matter induces a NASH-like phenotype and impairs hepatic glucose metabolism in an animal model,” Journal of Hepatology, vol. 58, no. 1, pp. 148–154, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. W. Hao and Z. Xiangdong, “Inflammatory effects of inhalable particulate matter from different sources on respiratory tract in rats,” Journal of Environmental Health, vol. 23, pp. 123–125, 2006. View at Google Scholar
  17. United Nations, “Effects of ionizing radiation. Annex B: Epidemiological evaluation of cardiovascular disease and other non-cancer diseases following radiation exposure. United Nations Scientific Committee on the Effects of Atomic Radiation,” Report to the General Assembly, with Annexes UNSCEAR 2006, United Nations Sales Publications, New York, NY, USA, 2008. View at Google Scholar
  18. S. Pettit, E. Cresta, K. Winkley, E. Purssell, and J. Armes, “Glycaemic control in people with type 2 diabetes mellitus during and after cancer treatment: a systematic review and metaanalysis,” PLoS ONE, vol. 12, no. 5, Article ID e0176941, 2017. View at Google Scholar · View at Scopus
  19. International Commission on Radiological Protection, “Risk estimation for multifactorial diseases. A report of the International Commission on Radiological Protection,” Annals of the ICRP, vol. 29, no. 3-4, pp. 1–144, 1999. View at Google Scholar
  20. F. de Vathaire, C. El-Fayech, F. F. Ben Ayed et al., “Radiation dose to the pancreas and risk of diabetes mellitus in childhood cancer survivors: a retrospective cohort study,” The Lancet Oncology, vol. 13, no. 10, pp. 1002–1010, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. L. Dafeng, Z. Jinpeng, W. Zijun et al., “Investigation on the incidence of obesity, metabolic syndrome and diabetes in a nuclear power plant in China,” Chinese Journal of Radiation Health, vol. 23, pp. 107–111, 2014. View at Google Scholar
  22. D. Schaue, E. D. Micewicz, J. A. Ratikan, M. W. Xie, G. Cheng, and W. H. McBride, “Radiation and inflammation,” Seminars in Radiation Oncology, vol. 25, no. 1, pp. 4–10, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. D. Schaue, E. L. Kachikwu, and W. H. McBride, “Cytokines in radiobiological responses: a review,” Journal of Radiation Research, vol. 178, no. 6, pp. 505–523, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Shuo, M. Mai, Z. Yuqing et al., “Effect of insulin pump on insulin resistance and inflammatory factor levels in type 2 diabetic patients,” Journal of Difficult Diseases, vol. 15, pp. 1127–1130, 2016. View at Google Scholar
  25. M. Xiumei, C. Haiyan, B. Yongrui et al., “Analysis of related factors of radiation pneumonitis in patients with lung cancer treated by reverse intensity modulated radiation therapy,” Journal of Shanghai Jiaotong University: Medical Edition, vol. 33, pp. 485–488, 2013. View at Google Scholar
  26. C. Makine, Ç. Karşidaǧ, P. Kadioǧlu et al., “Symptoms of depression and diabetes specific emotional distress are associated with a negative appraisal of insulin therapy in insulin-naive patients with type 2 diabetes mellitus: a study from the European Depression in Diabetes (EDID) Research Consortium,” Diabetic Medicine, vol. 26, no. 1, pp. 28–33, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. B. Petrlová, H. Rosolova, Z. Hess, J. Podlipný, and J. Šimon, “Depressive disorders and the metabolic syndrome of insulin resistance,” Seminars in Vascular Medicine, vol. 4, no. 2, pp. 161–165, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Chen, Q. Zhang, G. Dai et al., “Association of depression with pre-diabetes, undiagnosed diabetes, and previously diagnosed diabetes: a meta-analysis,” Endocrine Journal, vol. 53, no. 1, pp. 35–46, 2016. View at Publisher · View at Google Scholar · View at Scopus
  29. V. D. Sousa, J. A. Zauszniewski, C. M. Musil, P. E. McDonald, and S. E. Milligan, “Testing a conceptual framework for diabetes self-care management.,” Research and Theory for Nursing Practice, vol. 18, no. 4, pp. 293–316, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Tomita, N. Yasui-Furukori, T. Nakagami et al., “The Influence of 5-HTTLPR genotype on the association between the plasma concentration and therapeutic effect of paroxetine in patients with major depressive disorder,” PLoS ONE, vol. 9, no. 5, pp. 185–189, 2014. View at Publisher · View at Google Scholar
  31. T. Tomita, M. Ishioka, A. Kaneda et al., “An investigation of temperament and character inventory items for predicting the response to paroxetine treatment in patients with major depressive disorder,” Journal of Affective Disorders, vol. 165, pp. 109–113, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. J. E. Aikens, D. W. Perkins, B. Lipton, and J. D. Piette, “Longitudinal analysis of depressive symptoms and glycemic control in type 2 diabetes,” Diabetes Care, vol. 32, no. 7, pp. 1177–1181, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. X. Li, F. Yu, Y. Zhou, and J. He, “Association between alcohol consumption and the risk of incident type 2 diabetes: a systematic review and dose-response meta-analysis,” American Journal of Clinical Nutrition, vol. 103, no. 3, pp. 818–829, 2016. View at Publisher · View at Google Scholar
  34. T. Ramirez, L. Longato, M. Tong, J. R. Wands, S. M. de la Monte, and M. Dostalek, “Insulin resistance, ceramide accumulation and endoplasmic reticulum stress in experimental chronic alcohol-induced steatohepatitis,” Alcohol and Alcoholism, vol. 48, no. 1, pp. 39–52, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. N. Y. Elmadhun, A. D. Lassaletta, T. Burgess, A. A. Sabe, and F. W. Sellke, “Alcohol consumption improves insulin signaling in the myocardium,” Surgery, vol. 154, no. 2, pp. 320–327, 2013. View at Google Scholar · View at Scopus
  36. D. Lee, M. Yoo, H. Kim et al., “Association between alcohol consumption pattern and the incidence risk of type 2 diabetes in Korean men: a 12-years follow-up study,” Scientific Reports, vol. 7, pp. 1–7, 2017. View at Publisher · View at Google Scholar
  37. M. Cullmann, A. Hilding, and C.-G. Östenson, “Alcohol consumption and risk of pre-diabetes and type 2 diabetes development in a Swedish population,” Diabetic Medicine, vol. 29, no. 4, pp. 441–452, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. S.-W. Hong, J. A. Linton, J.-Y. Shim, and H.-T. Kang, “High-risk drinking is associated with a higher risk of diabetes mellitus in Korean men, based on the 2010-2012 KNHANES,” Alcohol, vol. 49, no. 3, pp. 275–281, 2015. View at Publisher · View at Google Scholar · View at Scopus
  39. S. N. Rajpathak, M. S. Freiberg, C. Wang et al., “Alcohol consumption and the risk of coronary heart disease in postmenopausal women with diabetes: women's health initiative observational study,” European Journal of Nutrition, vol. 49, no. 4, pp. 211–218, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. A. D. Smith, A. Crippa, J. Woodcock, and S. Brage, “Physical activity and incident type 2 diabetes mellitus: a systematic review and dose–response meta-analysis of prospective cohort studies,” Diabetologia, vol. 59, no. 12, pp. 2527–2545, 2016. View at Publisher · View at Google Scholar · View at Scopus
  41. S. R. Colberg, R. J. Sigal, B. Fernhall et al., “Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement,” Diabetes Care, vol. 33, no. 12, pp. 2692–2696, 2010. View at Google Scholar
  42. M. Chao, C. Wang, X. Dong, and M. Ding, “The effects of Tai Chi on type 2 diabetes mellitus: a meta-analysis,” Journal of Diabetes Research, vol. 2018, Article ID 7350567, 9 pages, 2018. View at Publisher · View at Google Scholar
  43. R. Song, S. Ahn, B. Roberts, E. O. Lee, and Y. H. Ahn, “Adhering to a tai chi program to improve glucose control and quality of life for individuals with type 2 diabetes,” Journal of Alternative and Complementary Medicine, vol. 15, no. 6, pp. 627–632, 2009. View at Google Scholar
  44. T. Liu, S. Bai, and R. C. Zhang, “Effects of Health Qigong Baduanjin on diabetes related indexes in middle-aged obese women,” Zhongguo Ying Yong Sheng Li Xue Za Zhi, vol. 34, pp. 19–22, 2018. View at Google Scholar
  45. L. Xiaobing, “Effect of Taijiquan exercise on oxidative stress and inflammation in elderly patients with type 2 diabetes,” Chinese Journal of Gerontology, vol. 21, pp. 5465-5466, 2013. View at Google Scholar
  46. W. J. Cao, “Tai Chi old obese type II neuropeptide Y impact,” Physical and Science, vol. 24, no. 72, pp. 67-68, 2003. View at Google Scholar
  47. L. Yanjiao, S. Shuchen, Y. Xue et al., “2017 review report of the federation of traditional chinese medicine societies sleep medicine committee,” World Journal of Sleep Medicine, vol. 5, pp. 112-113, 2018. View at Google Scholar
  48. D. Foley, S. Ancoli-Israel, P. Britz, and J. Walsh, “Sleep disturbances and chronic disease in older adults: results of the 2003 national sleep foundation sleep in america survey,” Journal of Psychosomatic Research, vol. 56, no. 5, pp. 497–502, 2004. View at Publisher · View at Google Scholar · View at Scopus
  49. S. Katano, Y. Nakamura, A. Nakamura et al., “Association of short sleep duration with impaired glucose tolerance or diabetes mellitus,” Journal of Diabetes Investigation, vol. 2, no. 5, pp. 366–372, 2011. View at Publisher · View at Google Scholar · View at Scopus
  50. K. L. Knutson, E. Van Cauter, P. Zee, K. Liu, and D. S. Lauderdale, “Cross-sectional associations between measures of sleep and markers of glucose metabolism among subjects with and without diabetes: the Coronary Artery Risk Development in Young Adults (CARDIA) sleep study,” Diabetes Care, vol. 34, no. 5, pp. 1171–1176, 2011. View at Publisher · View at Google Scholar · View at Scopus
  51. M. R. Irwin, M. Wang, D. Ribeiro et al., “Sleep loss activates cellular inflammatory signaling,” Biological Psychiatry, vol. 64, no. 6, pp. 538–540, 2008. View at Publisher · View at Google Scholar · View at Scopus
  52. J.-K. Chiang, “Short duration of sleep is associated with elevated high- sensitivity C-reactive protein level in Taiwanese adults: a cross-sectional study,” Journal of Clinical Sleep Medicine, vol. 10, no. 7, pp. 743–749, 2014. View at Google Scholar · View at Scopus
  53. D. Tamada, M. Otsuki, S. Kashine et al., “Obstructive sleep apnea syndrome causes a pseudo- Cushing's state in Japanese obese patients with type 2 diabetes mellitus,” Endocrine Journal, vol. 60, no. 12, pp. 1289–1294, 2013. View at Publisher · View at Google Scholar · View at Scopus
  54. A. M. Bao, G. Meynen, and D. F. Swaab, “The stress system in depression and neurodegeneration: focus on the human hypothalamus,” Brain Research Reviews, vol. 57, no. 2, pp. 531–553, 2008. View at Publisher · View at Google Scholar · View at Scopus
  55. A. Quercioli, F. Mach, and F. Montecucco, “Inflammation accelerates atherosclerotic processes in obstructive sleep apnea syndrome (OSAS),” Sleep and Breathing, vol. 14, no. 3, pp. 261–269, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. S. M. Jin and J. H. Kim, “Management of adults with type 1 diabetes: current status and suggestions,” Journal of Korean Diabetes, vol. 15, no. 1, pp. 1–6, 2014. View at Google Scholar
  57. M. R. Meyer, D. J. Clegg, E. R. Prossnitz, and M. Barton, “Obesity, insulin resistance and diabetes: sex differences and role of oestrogen receptors,” Acta Physiologica (Oxford, England), vol. 203, no. 1, pp. 259–269, 2011. View at Publisher · View at Google Scholar · View at Scopus